Kindred Healthcare (KND) Sees Significant Decrease in Short Interest
Kindred Healthcare (NYSE:KND) was the target of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 2,432,020 shares, a decline of 48.0% from the April 13th total of 4,675,149 shares. Based on an average daily volume of 962,610 shares, the short-interest ratio is currently 2.5 days. Approximately 2.8% of the company’s stock are sold short.
Several research firms have recently issued reports on KND. ValuEngine cut shares of Kindred Healthcare from a “sell” rating to a “strong sell” rating in a research report on Friday, May 4th. Zacks Investment Research cut shares of Kindred Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, April 24th. Three investment analysts have rated the stock with a sell rating and five have issued a hold rating to the company. The stock has a consensus rating of “Hold” and an average target price of $8.33.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Ancora Advisors LLC purchased a new stake in Kindred Healthcare in the first quarter valued at $137,000. Susquehanna Fundamental Investments LLC purchased a new stake in Kindred Healthcare in the first quarter valued at $313,000. UBS Group AG lifted its position in Kindred Healthcare by 46,724.7% in the first quarter. UBS Group AG now owns 2,564,122 shares of the health services provider’s stock valued at $23,461,000 after acquiring an additional 2,558,646 shares during the last quarter. Prosight Management LP purchased a new stake in Kindred Healthcare in the first quarter valued at $1,485,000. Finally, Water Island Capital LLC purchased a new stake in Kindred Healthcare in the first quarter valued at $28,103,000. 88.39% of the stock is owned by hedge funds and other institutional investors.
Kindred Healthcare (NYSE:KND) last announced its quarterly earnings results on Wednesday, February 28th. The health services provider reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.02. Kindred Healthcare had a negative net margin of 11.56% and a positive return on equity of 11.38%. The firm had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the previous year, the company earned $0.05 earnings per share. Kindred Healthcare’s quarterly revenue was down 2.2% compared to the same quarter last year. sell-side analysts predict that Kindred Healthcare will post 0.64 earnings per share for the current fiscal year.
Kindred Healthcare Company Profile
Kindred Healthcare, Inc provides healthcare services in the United States. It operates through five segments: Home Health Services, Hospice Services, Hospitals, Kindred Hospital Rehabilitation Services, and RehabCare. The company provides long-term acute care (LTAC) services to post-intensive care and medically complex patients, including the critically ill and suffering from multiple organ system failures most commonly of the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems.
Receive News & Ratings for Kindred Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.